Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/21/2025

Basal Insulin Dosing Guidelines

Introduction to Basal Insulin Therapy

  • The American Diabetes Association guidelines emphasize that practitioners should be aware of the 0.5 units/kg/day threshold for basal insulin, regardless of the absolute total dose 2
  • When basal insulin approaches or exceeds 0.5 units/kg/day, practitioners should strongly consider adding prandial insulin rather than continuing to escalate basal insulin 1, 2
  • The American Diabetes Association recommends that basal insulin dosing should be guided by clinical response, with particular attention to signs of "overbasalization" when doses exceed 0.5 units/kg/day 1, 2

Key Dosing Thresholds and Clinical Decision Points

  • The American Diabetes Association guidelines suggest that as basal insulin doses approach 1.0 units/kg/day, the need for prandial insulin therapy becomes highly likely, especially if A1C remains above goal despite achieving fasting glucose targets 2
  • Initial dosing for insulin-naïve patients with type 2 diabetes is 10 units per day or 0.1-0.2 units/kg/day 1, 3
  • For patients with type 2 diabetes and moderate hyperglycemia, a dose of 0.2-0.3 units/kg/day may be appropriate 5
  • For patients with type 2 diabetes and severe hyperglycemia, a dose of 0.3-0.5 units/kg/day may be reasonable 2, 6

Signs of Overbasalization

  • Bedtime-to-morning glucose differential ≥50 mg/dL is a sign of overbasalization 1, 4
  • Basal insulin dose >0.5 units/kg/day is a sign of overbasalization 1, 4
  • Hypoglycemia, high glucose variability, and postprandial-to-preprandial glucose differential elevation are also signs of overbasalization 1

Typical Dosing Ranges by Clinical Context

  • For type 1 diabetes, total daily insulin requirements are typically 0.4-1.0 units/kg/day, with approximately 40-50% allocated to basal insulin 1, 3, 4
  • For hospitalized patients, initial dosing is 0.3-0.5 units/kg total daily dose, with half as basal insulin 5, 6
  • For high-risk patients, lower doses of 0.1-0.25 units/kg/day may be appropriate 5, 6

The Critical Pitfall: Continuing to Escalate Basal Insulin Beyond Appropriate Limits

  • Continuing to increase basal insulin beyond 0.5-1.0 units/kg/day without addressing postprandial hyperglycemia can lead to suboptimal glycemic control, increased hypoglycemia risk, and weight gain without corresponding glycemic benefit 2, 4, 6

When to Add Prandial Insulin Instead of Increasing Basal Insulin

  • Add prandial insulin when fasting glucose is at target but A1C remains above goal after 3-6 months of basal insulin titration 2
  • Add prandial insulin when significant postprandial glucose excursions occur (>180 mg/dL) 2
  • Add prandial insulin when basal insulin dose approaches 0.5 units/kg/day and A1C goals are not met 2, 4

Prandial Insulin Initiation

  • Start with 4 units of rapid-acting insulin before the largest meal, or 10% of the basal insulin dose 1, 3
  • Add to additional meals sequentially based on glucose patterns 1, 2

Hypoglycemia Management and Dose Reduction

  • For any hypoglycemia episode, determine the cause first and lower the corresponding dose by 10-20% if no clear reason is identified 1, 3

Alternative Strategies at High Basal Doses

  • Consider adding a GLP-1 receptor agonist to basal insulin when basal insulin requirements are high and A1C remains elevated 2
  • Fixed-ratio combination products (IDegLira or iGlarLixi) may be appropriate for patients on both GLP-1 RA and basal insulin 1
  • Thiazolidinediones may be helpful in certain individuals with severe insulin resistance and large insulin requirements, though they should be used cautiously due to edema and weight gain risks 2